CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 53 enrolled
Drug / intervention
Screening Wizardbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03985813
NCT03985813N/ACompleted
CompareCT.gov

Screening Wizard, Component 1 of iCHART (Integrated Care to Help At-Risk Teens)-Feasibility/Pilot Phase

University of Pittsburgh·interventional·Posted Jun 14, 2019·Updated Jul 15, 2022

In Brief

A clinical study evaluating Screening Wizard for Depression and Suicidal Ideation. Completed, enrolled 53 participants across 4 sites.

Detailed Summary

Screening Wizard (SW). Primary Care Providers (PCPs) are often uncertain about how to best refer adolescents who screen positive for depression or suicidality. Screen-positive youth who are either not in treatment, or express dissatisfaction with current treatment will be consented by an on-site research assistant (RA). Those parents and patients receiving SW will answer additional questions: adaptive screens developed in a previous NIMH study (MH100155) for suicidal risk, anxiety, and mania; perceived barriers; and preferences about treatment. SW generates recommendations for PCPs reflecting patient clinical needs and preferences.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression, Suicidal Ideation
CountriesUnited States
CollaboratorsKaiser Foundation Research Institute, National Institute of Mental Health (NIMH)

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 14, 2019
Enrollment StartAug 13, 2019
Primary CompletionOct 15, 2020
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 7.0 years ago

Interventions

Screening Wizardbehavioral

Screening Wizard is a decision support tool to guide the primary care provider to make a referral that reflects patient clinical needs and patient and parental treatment preferences and perceived barriers to treatment.